AEM vs FSI

AEM's deterministic health score is concerning with a Piotroski F-Score of 4/9, indicating marginal financial stability, while the absence of an Altman Z-Score limits distress risk assessment. Despite strong profitability metrics—ROE of 15.67%, gross margin of 70.24%, and robust earnings growth of 85.8% YoY—the stock trades at a premium valuation (P/E 31.23 vs sector avg 25.89) above both the Graham Number ($85.07) and intrinsic value estimate ($202.66). Strong recent price performance (+145% 1Y) and analyst buy recommendation are counterbalanced by weak technical trend (10/100) and limited insider sentiment (40/100). The balance between operational strength and valuation concerns leads to a neutral stance.

FSI presents a stable but mediocre Piotroski F-Score of 4/9, yet it is fundamentally disconnected from its valuation metrics. The stock trades at $6.58, representing a massive premium over its Graham Number ($2.04) and Intrinsic Value ($0.42). With negative operating margins (-1.20%), stagnant revenue growth (-0.50%), and a dismal earnings track record (0/4 beats in the last year), the current price is speculative. This bearish outlook is further reinforced by aggressive insider selling by the CEO and a technical trend score of 0/100.